Dr. Karen A. Fagan, MD

Dr. Fagan practices at Medical Faculty Associates, Inc in Washington, District of Columbia.

Dr. Fagan's NPI, 1053401737, was assigned on October 13, 2006. Dr. Fagan graduated from University of California, San Diego School of Medicine in 1992. Dr. Fagan holds Alabama license 28767.

Dr. Fagan's primary practice is Medical Faculty Associates, Inc, at 2150 Pennsylvania NW Ave, Washington, DC 20037 in District Of Columbia County. The practice phone is (202) 741-3350.

Dr. Fagan's primary practice is Medical Faculty Associates, Inc in Washington, District of Columbia. Dr. Fagan is also affiliated with The George Washington University Hospital. The medical group on file is The GW Medical Faculty Associates. Dmand AI also links Dr. Fagan to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fagan practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Fagan's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Fagan is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Fagan's licenses on file in 2 states: Alabama and Colorado.

CMS data shows 133 Medicare services from Dr. Fagan across 4 procedure codes in 2024, for 92 Medicare patients. Medicare paid $11,645 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 92 Medicare patients who saw Dr. Fagan in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 38% are also on Medicaid. Their average risk score is 3.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fagan's median patient age at 71, with 64% women.

In 2024, Dr. Fagan wrote 697 Medicare Part D claims for 94 patients. 51% of them were for generic drugs. CMS names the drug for 549 of them, across 17 drugs with 11 or more claims each, at $3,156,444 in total drug cost. In 2023, CMS named 762 claims across 19 drugs.

Dr. Fagan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Fagan, published from 2010 to 2020. 2011 was the busiest year, with 2. The most frequent topics are Hypertension, Pulmonary, Antihypertensive Agents and Blood Pressure. Dr. Fagan has published most often in Am J Respir Crit Care Med. Dr. Fagan's most frequent co-authors are Steven Mark Kawut, MD, Kurt Stenmark, MD and Jason M. Aliotta, MD.

Dmand AI links Dr. Fagan to 2 clinical trials. Conditions studied include Emphysema, Pulmonary Arterial Hypertension and Hypertension, Pulmonary.

CMS Open Payments shows 497 general payments to Dr. Fagan from 59 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $1,976.

Dr. Fagan graduated from University of California, San Diego School of Medicine in 1992.